Patents by Inventor Martin Radtke

Martin Radtke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of depositing a coating utilizing a coating apparatus
    Patent number: 11820700
    Abstract: A method of depositing a coating utilizing a coating apparatus includes providing a coating apparatus above a glass substrate and forming a coating on a surface of the glass substrate while flowing a fluorine-containing compound into the coating apparatus. The fluorine-containing compound inhibits the formation of the coating on one or more portions of the coating apparatus.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: November 21, 2023
    Assignee: Pilkington Group Limited
    Inventors: Michael Martin Radtke, Steven Edward Phillips
  • METHOD OF DEPOSITING A COATING UTILIZING A COATING APPARATUS
    Publication number: 20210101827
    Abstract: A method of depositing a coating utilizing a coating apparatus includes providing a coating apparatus above a glass substrate and forming a coating on a surface of the glass substrate while flowing a fluorine-containing compound into the coating apparatus. The fluorine-containing compound inhibits the formation of the coating on one or more portions of the coating apparatus.
    Type: Application
    Filed: December 18, 2020
    Publication date: April 8, 2021
    Applicant: PILKINGTON GROUP LIMITED
    Inventors: MICHAEL MARTIN RADTKE, STEVEN EDWARD PHILLIPS
  • Chemical vapor deposition process for depositing a silica coating on a glass substrate
    Patent number: 10837108
    Abstract: A CVD process for depositing a silica coating is provided. The process includes providing a float glass ribbon in a float glass manufacturing process. The process also includes forming a gaseous mixture including a silane compound, oxygen, a fluorine-containing compound, and a radical scavenger. The gaseous mixture is directed toward and along the float glass ribbon and is reacted over the float glass ribbon to form the silica coating thereon. The silica coating comprises silicon dioxide.
    Type: Grant
    Filed: June 29, 2016
    Date of Patent: November 17, 2020
    Assignee: Pilkington Group Limited
    Inventors: Douglas Martin Nelson, Michael Martin Radtke, Steven Edward Phillips
  • CHEMICAL VAPOR DEPOSITION PROCESS FOR DEPOSITING A SILICA COATING ON A GLASS SUBSTRATE
    Publication number: 20160305021
    Abstract: A CVD process for depositing a silica coating is provided. The process includes providing a float glass ribbon in a float glass manufacturing process. The process also includes forming a gaseous mixture including a silane compound, oxygen, a fluorine-containing compound, and a radical scavenger. The gaseous mixture is directed toward and along the float glass ribbon and is reacted over the float glass ribbon to form the silica coating thereon. The silica coating comprises silicon dioxide.
    Type: Application
    Filed: June 29, 2016
    Publication date: October 20, 2016
    Inventors: Douglas Martin Nelson, Michael Martin Radtke, Steven Edward Phillips
  • Chemical vapor deposition process for depositing a silica coating on a glass substrate
    Patent number: 9404179
    Abstract: A CVD process for depositing a silica coating is provided. The process includes providing a glass substrate. The process also includes forming a gaseous mixture including a silane compound, oxygen, a fluorine-containing compound, and a radical scavenger such as ethylene or propylene. The gaseous mixture is directed toward and along the glass substrate and is reacted over the glass substrate to form the silica coating thereon.
    Type: Grant
    Filed: February 18, 2013
    Date of Patent: August 2, 2016
    Assignee: PILKINGTON GROUP LIMITED
    Inventors: Douglas Martin Nelson, Michael Martin Radtke, Steven Edward Phillips
  • METHOD OF DEPOSITING A COATING UTILIZING A COATING APPARATUS
    Publication number: 20160016847
    Abstract: A method of depositing a coating utilizing a coating apparatus includes providing a coating apparatus above a glass substrate and forming a coating on a surface of the glass substrate while flowing a fluorine-containing compound into the coating apparatus. The fluorine-containing compound inhibits the formation of the coating on one or more portions of the coating apparatus.
    Type: Application
    Filed: July 16, 2013
    Publication date: January 21, 2016
    Applicant: PILKINGTON GROUP LIMITED
    Inventor: Michael Martin Radtke
  • CHEMICAL VAPOR DEPOSITION PROCESS FOR DEPOSITING A SILICA COATING ON A GLASS SUBSTRATE
    Publication number: 20150140216
    Abstract: A CVD process for depositing a silica coating is provided. The process includes providing a glass substrate. The process also includes forming a gaseous mixture including a silane compound, oxygen, a fluorine-containing compound, and a radical scavenger such as ethylene or propylene. The gaseous mixture is directed toward and along the glass substrate and is reacted over the glass substrate to form the silica coating thereon.
    Type: Application
    Filed: February 18, 2013
    Publication date: May 21, 2015
    Inventors: Douglas Nelson, Michael Martin Radtke, Steven Edward Phillips
  • Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
    Patent number: 8410090
    Abstract: The invention relates to heterocyclylamide-substituted thiazoles, pyrroles and thiophenes and processes for their preparation, to pharmaceutical compositions containing them, and to their use for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.
    Type: Grant
    Filed: July 1, 2006
    Date of Patent: April 2, 2013
    Assignee: AiCuris GmbH & Co. KG
    Inventors: Holger Zimmermann, David Brueckner, Kerstin Henninger, Martin Hendrix, Martin Radtke
  • Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors
    Patent number: 8329716
    Abstract: The invention relates to hetaryloxy-substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: December 11, 2012
    Assignee: Bayer Intellectual Property GmbH
    Inventors: Hartmut Schirok, Martin Radtke, Joachim Mittendorf, Raimund Kast, Johannes-Peter Stasch, Mark Jean Gnoth, Klaus Münter, Dieter Lang, Santiago Figueroa Perez, Michael Thutewohl, Samir Bennabi, Heimo Ehmke
  • 3-Cyanoalkyl- and 3-hydroxyalkylindoles and use thereof
    Publication number: 20110183928
    Abstract: The present application relates to novel 3-cyanoalkyl- and 3-hydroxyalkyl-substituted indole derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of cardiovascular diseases.
    Type: Application
    Filed: June 18, 2009
    Publication date: July 28, 2011
    Applicant: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
    Inventors: Kai Thede, Elisabeth Woltering, Peter Kolkhof, Carsten Schmeck, Elisabeth Pook, Alexander Hillisch, Lars Bärfacker, Klemens Lustig, Dieter Lang, Martin Radtke, Rolf Grosser, Astrid Brüns, Michael Gerisch
  • Heterocyclyamide-substituted imidazoles
    Patent number: 7919489
    Abstract: The invention relates to heterocyclylamide-substituted imidazoles and methods for their preparation, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.
    Type: Grant
    Filed: August 20, 2007
    Date of Patent: April 5, 2011
    Assignee: Aicuris GmbH & Co. KG
    Inventors: Holger Zimmermann, David Brueckner, Kerstin Henninger, Ulrich Rosentreter, Martin Hendrix, Joerg Keldenich, Dieter Lang, Martin Radtke, Daniela Paulsen, Armin Kern
  • Antiviral 4-aminocarbonylamino-substituted imidazole compounds
    Patent number: 7767704
    Abstract: The invention relates to the substituted imidazoles of formula (I) and to methods for producing the same, to their use in the treatment and/or prophylaxis of diseases and to their use for producing drugs for use in the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, especially against cytomegaloviruses.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: August 3, 2010
    Assignee: AiCuris GmbH & Co. KG
    Inventors: Holger Zimmermann, David Brueckner, Dirk Heimbach, Martin Hendrix, Kerstin Henninger, Guy Hewlett, Ulrich Rosentreter, Joerg Keldenich, Dieter Lang, Martin Radtke
  • Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
    Publication number: 20100144752
    Abstract: The invention relates to heterocyclylamide-substituted thiazoles, pyrroles and thiophenes and to processes for preparing them, to their use for the treatment and/or prophylaxis of diseases, and to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, particularly for use as antiviral agents, especially against cytomegaloviruses.
    Type: Application
    Filed: July 1, 2006
    Publication date: June 10, 2010
    Inventors: Holger Zimmermann, David Brückner, Kerstin Henninger, Martin Hendrix, Martin Radtke
  • Substituted phenylamino-pyrimidines
    Patent number: 7723347
    Abstract: The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Grant
    Filed: April 14, 2005
    Date of Patent: May 25, 2010
    Assignee: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Hartmut Schirok, Johannes-Peter Stasch, Raimund Kast, Klaus Münter, Marc Jean Gnoth, Santiago Figureoa Perez, Michael Thutewohl, Samir Bennabi, Dieter Lang, Joachim Mittendorf, Martin Radtke, Heimo Ehmke
  • Substituted Phenylamino-Pyrimidines
    Publication number: 20080269268
    Abstract: The invention relates to substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Application
    Filed: April 14, 2005
    Publication date: October 30, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Hartmut Schirok, Johannes-Peter Stasch, Raimund Kast, Klaus Munter, Mark Jean Gnoth, Santiago Figureoa Perez, Michael Thutewohl, Samir Bennabi, Dieter Lang, Joachim Mittendorf, Martin Radtke, Heimo Ehmke
  • HETEROCYCLYAMIDE-SUBSTITUTED IMIDAZOLES
    Publication number: 20080176859
    Abstract: The invention relates to heterocyclylamide-substituted imidazoles and methods for their preparation, their use for the treatment and/or prophylaxis of diseases as well as their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular for the use as antiviral agents, especially against cytomegaloviruses.
    Type: Application
    Filed: August 20, 2007
    Publication date: July 24, 2008
    Inventors: Holger ZIMMERMANN, David BRUECKENER, Kerstin HENNINGER, Ulrich ROSENTRETER, Martin HENDRIX, Joerg KELDENICH, Dieter LANG, Martin RADTKE, Daniela PAULSEN, Armin KERN
  • Hetaryloxy-Substituted Phenylamino Pyrimidines as Rho Kinase Inhibitors
    Publication number: 20080139595
    Abstract: The invention relates to hetaryloxy-substituted phenylaminopyrimidines, to a process for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases in humans and animals, in particular cardiovascular disorders.
    Type: Application
    Filed: March 30, 2005
    Publication date: June 12, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Hartmut Schirok, Martin Radtke, Joachim Mittendorf, Raimund Kast, Johannes-Peter Stasch, Mark Jean Gnoth, Klaus Munter, Dieter Lang, Santiago Figueroa Perez, Michael Thutewohl, Samir Bennabi, Heimo Ehmke
  • Antiviral 4-Aminocarbonylamino-Substituted Imidazole Compounds
    Publication number: 20080004275
    Abstract: The invention relates to the substituted imidazoles of formula (I) and to methods for producing the same, to their use in the treatment and/or prophylaxis of diseases and to their use for producing drugs for use in the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, especially against cytomegaloviruses.
    Type: Application
    Filed: March 11, 2005
    Publication date: January 3, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Holger Zimmermann, David Bruckner, Dirk Heimbach, Martin Hendrix, Kerstin Henninger, Guy Hewlett, Ulrich Rosentreter, Jorg Keldenich, Dieter Lang, Martin Radtke
  • Arylsulfonamides as antiviral agents
    Patent number: 7115612
    Abstract: The present invention relates to novel sulphonamides of the general formula (I) in which the substituents R1, R2, R3, R4 and A and X are as defined in claim 1 and other claims, and also to processes for their preparation and to their use as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: April 8, 2002
    Date of Patent: October 3, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jörg Keldenich, Armin Kern, Siegfried Raddatz, Jürgen Reefschläger, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke
  • Hetrocyclic aryl sulphonamides
    Patent number: 7115636
    Abstract: The invention relates to novel sulfonamides of general formula (I) where the substituents R1, R2, R3, R4, A and X have the given meanings, pharmaceutical compositions containing them, and a method of using them as antiviral agents, in particular against cytomegaloviruses.
    Type: Grant
    Filed: July 24, 2002
    Date of Patent: October 3, 2006
    Assignee: Bayer Healthcare AG
    Inventors: Tobias Wunberg, Wolfgang Bender, Peter Eckenberg, Sabine Hallenberger, Kerstin Henninger, Jörg Keldenich, Armin Kern, Siegfried Raddatz, Jürgen Reefschläger, Gunter Schmidt, Holger Zimmermann, Franz Zumpe, Martin Radtke